Saturday July 04 2009 |
Biotechnology feed
|
All feeds
Home
Marketing Services
Antibodies
Careers
Directories
Drugs
Events
Genes
InDepth
News
Reports
Videos
A-Z
Business
Health
Drugs
Sources
Americas
Europe
Asia
Cancer
Cardio-
Diabetes
Bird Flu
Swine Flu
Summaries
Post News
Search
Narcolepsy News and Headlines
Narcolepsy News updated every 30 minutes from thousands of internet sites.
Sign-up to BioPortfolio's
Narcolepsy
news alerts
.
Site Map
>
Biotechnology News
>
Health News
> Narcolepsy
.
What Is Narcolepsy? What Causes Narcolepsy?
Medical News Today:
similar ...
[Review Articles] Orexin/Hypocretin: A Neuropeptide at the Interface of Sleep, Energy Homeostasis, and Reward
Pharmacological Reviews:
similar ...
Narcolepsy - Master of Disguise: Evidence-Based Recommendations for Management
MDLinx:
similar ...
Addrenex Pharmaceuticals Expands Product Pipeline by Licensing New Drug to Treat Narcolepsy
Pharma Live:
similar ...
Addrenex Pharmaceuticals Expands Product Pipeline by Licensing New Drug to Treat Narcolepsy
PR Newswire via Yahoo!:
similar ...
New European Approval for Xyrem Provides Significant Advance in the Treatment of Narcolepsy
All Material Subject to Copyright:
similar ...
UCB and Jazz Pharmaceuticals expand Xyrem license agreement to include fibromyalgia syndrome
Pain & Central Nervous System Week via NewsRx.com:
similar ...
Alfresa Pharma, Tanabe Seiyaku to Collaborate in Development and Sales of Narcolepsy Drug Modafinil
Copyright (C) 2006 Japan Corporate News Network. All rights reserved.:
similar ...
U.S. FDA approves therapy for excessive daytime sleepiness in narcolepsy patients
Medical Letter on the CDC & FDA via NewsRx.com:
similar ...
Xyrem(R) (Sodium Oxybate) Receives FDA Approval for the Treatment of Excessive Daytime Sleepiness in Patients With Narcolepsy
PR Newswire:
similar ...
Narcolepsy Drug Relieves Pain and Improves Sleep in Fibromyalgia Patients, Study Shows
PR Newswire:
similar ...
Alfresa Pharma Files Manufacturing Approval for Modafinil for Narcolepsy
Copyright (C) 2005 Japan Corporate News Network. All rights reserved.:
similar ...
FDA Accepts Xyrem sNDA for Review, User Fee Deadline Set for November 18, 2005, Company Receives $1 Million Payment from UCB Pharma Limited
Business Wire:
similar ...
SA/ Researchers find narcolepsy antibody
AAP NEWS:
similar ...
Orphan Medical Submits Xyrem sNDA to Include Improvement in Other Primary Symptoms of Narcolepsy; Approval Would Expand Addressable Market to Over
Business Wire:
similar ...
Pharma company releases number of Xyrem prescriptions filled - Narcolepsy
NewsRxCDC-FDA:
similar ...
Scientists take another step in understanding causes of sleep disorder - Narcolepsy
NewsRxPainCNS:
similar ...
Pharma company releases number of Xyrem prescriptions filled - Narcolepsy
NewsRxCDC-FDA:
similar ...
Scientists take another step in understanding causes of sleep disorder - Narcolepsy
NewsRxPainCNS:
similar ...
Phase II trial shows improvement in daytime sleepiness for narcoleptics - Narcolepsy
NewsRxDrugs:
similar ...
